Cancer Genetics Inc. (CGIX) Dipped -8.07% or -0.02 To Price $0.24 On Wednesday


Cancer Genetics Inc. (CGIX) dipped -8.07% or -0.02 to $0.24. It is close to 7.88 million shares traded, which is 472.75% compare to the average total volume 1.67 million. The market cap of CGIX is $13.42 million. The year to date change is -4.34%. The 52 week price range is from $0.2 to $1.3. Price of CGIX have changed 17.08% during last week. It have changed 8.01% over last month, -0.22% over last 3 months, -64.48% over last 6 months and -72.12% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CGIX is 0.25. It is 4.17% above current price. The 200-day Moving Averages for CGIX is 0.57. It is 137.50% above current price. The 52-week High is 1.3. It is 441.67% from the current price. The 52-week Low is 0.2. It is -16.67% from current price.

There are some statistics of CGIX. It is has market cap $13.42 million. The share outstanding is 56.28 million. The average volume is 1.67 million. The percent of top 15 Institution holding is 5.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CGIX is -125.67%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CGIX is -47.71%.


Tags:

Share this post